Dismissal of Prevagen case deals tough blow to FTC
When the Federal Trade Commission and New York’s attorney general joined forces to sue Quincy Bioscience for deceptive advertising in promoting Prevagen, a dietary supplement, the enforcers came out guns blazing....To view the full article, register now.
Already a subscriber? Click here to view full article